TELMISARTAN HCT ALSA 40/12.5mg telmisartan 40mg and hydrochlorothiazide 12.5mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

telmisartan, Quantity: 40 mg; hydrochlorothiazide, Quantity: 12.5 mg

Available from:

Alembic Pharmaceuticals Australia Pty Ltd

INN (International Name):

Hydrochlorothiazide,Telmisartan

Pharmaceutical form:

Tablet, multilayer

Composition:

Excipient Ingredients: sodium hydroxide; mannitol; povidone; lactose monohydrate; meglumine; magnesium stearate; sodium stearylfumarate; purified water; iron oxide red

Administration route:

Oral

Units in package:

28

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

TELMISARTAN HCT ALSA is indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.

Product summary:

Visual Identification: Oblong biconvex bilayered uncoated tablets with one white/off white color layer and one pink colour mottled layer debossed with L199; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-08-19